Bora CDMO Bora CDMO

X

Digital content for ABRAXIS BIOSCIENCE

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
ABRAXIS BIOSCIENCE
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
--
Telephone
Telephone
Client Website
Website
--
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

left grey arrow
right gray arrow

https://www.pharmacompass.com/pdf/news/abraxis-bioscience-on-health-canada-inspection-list-36076.pdf

HEALTH CANADA
07 Dec 2022

https://www.raps.org/news-and-articles/news-articles/2022/11/fda-says-abraxis-failed-to-proactively-address-rep

RAPS
10 Nov 2022

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/abraxis-bioscience-llc-633713-10312022

FDA
08 Nov 2022

https://www.indiainfoline.com/article/news-top-story/abraxis-biosciences-files-plea-against-sun-pharma-advanced-research-alleging-infringement-of-patent-119082100122_1.html

INDIAINFOLINE
20 Aug 2019

https://www.gene.com/media/press-releases/14709/2018-03-19/phase-iii-impower131-study-showed-genent

GENE.COM
20 Mar 2018

http://www.prnewswire.com/news-releases/tocagen-strengthens-leadership-team-martin-duvall-appointed-as-chief-executive-officer-300355715.html

PR NEWSWIRE
02 Nov 2016

http://www.financialexpress.com/article/industry/companies/abraxis-denied-patent-for-combination-of-taxane/192969/

FINANCIAL EXPRESS
12 Jan 2016

http://www.fiercebiotech.com/story/soon-shiongs-nantkwest-spending-more-stock-buybacks-rd/2015-11-13

Damian Garde FIERCE BIOTECH
14 Nov 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY